Ikena Oncology, Inc.IKNANASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+50.4%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+50.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.4x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20250.13+120.8%
20240.06-5.6%
20230.06+63.3%
20220.04+15.3%
20210.03+1925.7%
2020-0.00-
20190.00+100.0%
2018-1.37-